scholarly journals The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL

2012 ◽  
Vol 287 (39) ◽  
pp. 32875-32880 ◽  
Author(s):  
Hima Bansal ◽  
Theresea Seifert ◽  
Carlos Bachier ◽  
Manjeet Rao ◽  
Gail Tomlinson ◽  
...  
Keyword(s):  
Myeloid Leukemia ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Therapeutic Agent ◽  
Wilms Tumor ◽  
Leukemia Cells ◽  
Antiapoptotic Protein ◽  
Wilms Tumor 1 ◽  
Factor Α ◽  
Necrosis Factor

B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α

2005 ◽  
Vol 29 (7) ◽  
pp. 829-839 ◽  
Author(s):  
Emanuela Rosati ◽  
Rita Sabatini ◽  
Antonio Tabilio ◽  
Mauro Di Ianni ◽  
Andrea Bartoli ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
In Vitro Cytotoxicity ◽  
Lymphocytic Leukemia ◽  
Leukemia Cells ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Phase 2 Trial of Recombinant Tumor Necrosis Factor-α in Combination With Dactinomycin in Children With Recurrent Wilms Tumor

2008 ◽  
Vol 31 (7) ◽  
pp. 679-683 ◽  
Author(s):  
Holly J. Meany ◽  
Nita L. Seibel ◽  
Junfeng Sun ◽  
Jerry Z. Finklestein ◽  
Judith Sato ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Wilms Tumor ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Factor Α ◽  
Recombinant Tumor Necrosis Factor ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document